Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trial

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 9, 2005, Pages 1195-1202

  Sapoval, Marc ^a   Zähringer, Markus ^b   Pattynama, Peter ^c   Rabbia, Claudio ^d   Vignali, Claudio ^e   Maleux, Geert ^f   Boyer, Louis ^g   Szczerbo Trojanowska, Malgorzata ^h   Jaschke, Werner ⁱ   Hafsahl, Geir ^j   Downes, Mark ^k   Beregi, Jean Paul ^l   Veeger, Nic ^m   Talen, Aly ⁿ  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d AOU San Giovanni Battista di Torino   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g SERVICE DE RHUMATOLOGIE   (France)

^h University Hospital No 4   (Poland)

ⁱ UNIVERSITY OF INNSBRUCK   (Austria)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k Kent and Canterbury NHS Trust   (United Kingdom)

^l C2RM   (France)

^m Trial Coordination Center   (Netherlands)

ⁿ Talen Clinical Trial Management   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; DEVICE; FEMALE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STENT; VASCULAR PATENCY;

EID: 24944508027     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000171765.67665.D3     Document Type: Article

References (22)

1. Canzanello VJ, Millan VG, Spiegel JE, et al. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension 1989; 13:163-172.
2. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand. A meta-analysis. Radiology 2000; 216:78-85.
3. Zeller T, Frank U, Muller C, et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003; 1006-1014.
4. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2003; 14:S477-S492.
5. Palmaz JC, Sibbit RR, Reuter SR, et al. Expandable intraluminal graft: a preliminary study. Radiology 1985; 156: 73-7.
6. Palmaz JC, Kopp DT, Hayashi H, et al. Normal and stenotic renal arteries: experimental balloon-expandable intraluminal stenting. Radiology 1987; 164:705-708.
7. Rees CR, Palmaz JC, Becker GJ, et al. Palmaz stent in atherosclerotic stenosis involving the ostial of the renal arteries: preliminary report of a multicenter study. Radiology 1991; 181:507-514.
8. Dorros G, Prince C, Mathiak L. Stenting of renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 1993; 29:191-198.
9. Boisclair C, Therasse E, Oliva VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. AJR Am J Roentgenol 1997; 168:245-251.
10. Bakker J, Goffette PP, Henry M, et al. The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999; 468-474.
11. Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenosis with vascular endoprothesis after unsuccessful Balloon Angioplasty. N Engl J Med 1997; 459-465.
12. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001; 142(2): 314-23.
13. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? a meta-analysis of randomized control trials. Am J Med 2003; 114:44-50.
14. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003; 18:298-304.
15. Johnson & Johnson Interventional Systems Final progress report: Palmaz-Schatz balloon-expandable stent for use in renal arteries. IDE submission #G880303/S034; 15 January 1995.
16. van de Yen PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 23; 353:282-286.
17. Beek, FJ, Kaatee R, Beutler JJ, et al. Complications during renal artery stent placement for atherosclerotic ostial stenosis. Cardiovasc Intervent Radiol 1997; 20:184-190.
18. Kessel DO, Robertson I, Taylor EJ, Patel JV. Renal stenting from the radial artery: a novel approach. Cardiovasc Intervent Radiol 2003; 26:146-149.
19. Zeller T, Frank U, Müller U, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe artherosclerotic ostial renal artery stenosis. Circulation 2003; 108:2244.
20. Reddy BK, Kennedy DJ, Colyer WR, et al. Compliance with antihypertensive therapy after renal artery stenting. Biol Res Nurs 2003; 5:37-46.
21. Doty RL, Philip S, Reddy K, Kerr KL. Influences of antihypertensive and antihyperlipidemic drugs the senses of taste and smell: a review. J Hypertens 2003; 21:1805-1813.
22. Gascon JJ, Sánchez-Ortuno M, Llor B, et al. Why hypertensive patients do not comply with the treatment. Results from a qualitative study. Fam Pract 2004; 21:125-130.